Eli Lilly and Company

NYSE-LLY

Assets	Jun '25	Dec '24	Jun '24	Dec '23	Jun '23	Dec '22
Cash and Cash Equivalents	3,375.9	3,268.4	3,223.6	2,818.6	2,694.5	2,067
Cash and Cash Equivalents
Short-Term Investments	170.1	154.8	140.4	109.1	134.6	144.8
Short-Term Investments
Total Cash and Cash Equivalents	3,546	3,423.2	3,364	2,927.7	2,829.1	2,211.8
Accounts Receivable	14,170.4	11,005.7	11,027.9	9,090.5	7,516.1	6,896
Accounts Receivable, Net
Other Receivables	3,035.2	2,269.7	2,051.1	2,245.7	1,655.3	1,662.9
Other Receivables
Total Trade Receivables	17,205.6	13,275.4	13,079	11,336.2	9,171.4	8,558.9
Inventories	11,013.8	7,589.2	6,481.5	5,772.8	4,798.7	4,309.7
Inventories
Other Current Assets	18,088.6	8,451.9	7,279.8	5,690.3	4,532.4	2,954.1
Prepaid Expenses and Other
Current Assets of Discontinued Operations
Prepaid Expenses
Other Current Assets
Total Current Assets	49,854	32,739.7	30,204.3	25,727	21,331.6	18,034.5
Total Current Assets
Net Property, Plant & Equipment	20,529.7	17,102.4	14,829.4	12,913.6	11,277.4	10,144
Property and Equipment, Net
Operating Lease Assets
Net Intangible Assets	5,908.3	6,166.3	6,636.1	6,906.6	6,903.5	7,206.6
Other Intangibles, Net
Goodwill	5,770.5	5,770.3	5,768.2	4,939.7	4,078.9	4,073
Goodwill
Long-Term Investments	3,207.4	3,215.9	2,877.6	3,052.2	2,745.1	2,901.8
Investments
Other Long-Term Assets	15,652.7	13,720.3	11,559.2	10,467.2	8,477.5	7,129.9
Deferred Tax Assets
Sundry
Other Noncurrent Assets
Noncurrent Assets of Discontinued Operations
Total Assets	100,922.6	78,714.9	71,874.8	64,006.3	54,814	49,489.8
Total Assets

Liabilities	Jun '25	Dec '24	Jun '24	Dec '23	Jun '23	Dec '22
Accounts Payable	4,075.7	3,228.6	2,924.8	2,598.8	2,474.2	1,930.6
Accounts Payable
Accrued Expenses	1,303	2,093.9	1,168.3	1,650.4	867.7	1,059.8
Employee Compensation
Short-Term Debt	5,723.7	5,117.1	5,161.6	6,904.5	661.6	1,501.1
Short-Term Borrowings and Current Maturities of Long-Term Debt
Other Current Liabilities	27,917.5	17,937	17,866.5	16,139.5	14,911.5	12,646.7
Sales Rebates and Discounts
Dividends Payable
Short-Term Income Taxes Payable
Other Current Liabilities
Current Liabilities of Discontinued Operations
Total Current Liabilities	39,019.9	28,376.6	27,121.2	27,293.2	18,915	17,138.2
Total Current Liabilities
Long-Term Debt	34,180.1	28,527.1	23,730.4	18,320.8	18,158.4	14,737.5
Long-Term Debt
Leases	—	—	—	—	—	—
Noncurrent Operating Lease Liabilities
Other Long-Term Liabilities	9,373.5	7,539.6	7,387.7	7,528.6	6,591.3	6,838.7
Accrued Retirement Benefits
Long-Term Income Taxes Payable
Deferred Tax Liabilities
Noncurrent Liabilities of Discontinued Operations
Other Noncurrent Liabilities
Total Long-Term Liabilities	43,553.6	36,066.7	31,118.1	25,849.4	24,749.7	21,576.2
Total Noncurrent Liabilities
Total Liabilities	82,573.5	64,443.3	58,239.3	53,142.6	43,664.7	38,714.4

Equity	Jun '25	Dec '24	Jun '24	Dec '23	Jun '23	Dec '22
Common Stock	592	592.4	594.2	593.6	593.6	594.1
Common Stock
Treasury Stock	-55.4	-49.5	-32.7	-44.2	-45	-50.5
Cost of Common Stock in Treasury
Additional Paid-in Capital	7,089.3	7,439.3	7,214.2	7,250.4	6,948.6	6,921.4
Additional Paid-in Capital
Accumulated Other Comprehensive Income	-6,729.2	-7,335.1	-7,391.7	-7,340.2	-6,801.9	-6,857.8
Accumulated Other Comprehensive Loss
Employee Benefit Trust
Retained Earnings	17,376.2	13,545	13,178	10,312.3	10,368.5	10,042.6
Retained Earnings
Total Common Shareholders' Equity	18,272.9	14,192.1	13,562	10,771.9	11,063.8	10,649.8
Total Eli Lilly and Company Shareholders' Equity
Minority Interests and Other	76.2	79.5	73.5	91.8	85.5	125.6
Noncontrolling Interests
Total Shareholders' Equity	18,349.1	14,271.6	13,635.5	10,863.7	11,149.3	10,775.4
Total Equity
Total Liabilities and Shareholders' Equity	100,922.6	78,714.9	71,874.8	64,006.3	54,814	49,489.8
Total Liabilities and Equity